Eledon Pharmaceuticals, Inc. (ELDN) Q1 2026 Earnings
ELDN·Reported May 13, 2026·Before market open
Diluted EPS came in at $-0.33 (-312.5% YoY), missed the $-0.22 consensus by $0.11.
Diluted EPS
$-0.33missed by $0.11
Consensus: $-0.22
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Eledon Pharmaceuticals, Inc.'s Q1 2026 earnings report.
Eledon Pharmaceuticals, Inc. (ELDN) reported Q1 2026 earnings on May 13, 2026 before market open.
Eledon Pharmaceuticals, Inc. reported diluted EPS of $-0.33 for Q1 2026.
EPS missed the consensus estimate of $-0.22 by $0.11.
Compared to the same quarter a year prior, diluted EPS declined 312.5% from $-0.08.
You can read the 8-K earnings release (0001193125-26-221658) and the 10-Q periodic report (0001193125-26-221702) directly on SEC EDGAR. The filing index links above go to sec.gov.